Pharma giant tackling counterfeit drugs using blockchain
Fighting counterfeit drugs with blockchain technology… The Asia-Pacific pharmaceutical giant Zuellig pharma is using a blockchain platform by SAP to assist consumers identify the medicines place of origin. With 1 in 10 [...]
Pharma Industry Awards 2019 Finalists
MIAS Pharma are delighted to announce that we have been shortlisted in the Pharma Industry Awards 2019 for the 'Pharma Contract Services of the Year' category. The Pharma Industry Awards were set [...]
Further guidance on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal
The Medicines & Healthcare products Regulatory Agency (MHRA) have released further guidance on the regulation of medicines, medical devices and clinical trials if there is no Brexit deal. In relation to medicines: [...]
Hard-Brexit: MHRA preparations and impact on clinical trials
With the appointment of Boris Johnson as Prime Minister, it is likely that the United Kingdom (UK) may leave the European Union (EU) on the 31st of October 2019 and without a [...]
Hard-Brexit: MHRA preparations and impact on clinical trials
With the appointment of Boris Johnson as Prime Minister, it is likely that the United Kingdom (UK) may leave the European Union (EU) on the 31st of October 2019 and without a [...]
Safety is top concern for recent U.S. drug importation proposal
Last week, the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) released their “Safe Importation Action Plan”. The action plan would allow importation of [...]
Get Social